J&J is the third medtech company to gain U.S. approval for pulsed field ablation, a new atrial fibrillation treatment seeing ...

Dr. Mehran Attari, a cardiac electrophysiologist with Mercy Health, discusses a new treatment option for atrial fibrillation (AFib): pulse field ablation (PFA). Atrial fibrillation is the most common ...

FDA approves Johnson & Johnson's Varipulse for targeted atrial fibrillation treatment, enhancing precision and safety ...

The staff at Shasta Regional Medical Center (SRMC) is celebrating their 100th Watchman heart implant procedure, which took ...

Johnson & Johnson MedTech will enter the U.S. pulsed field ablation market following an FDA green light for its Varipulse ...

The terms “controlled AFib” and “uncontrolled AFib” describe whether treatment strategies are effectively managing a person’s irregular heart rate. Controlled AFib is when doctors have ...

The U.S. Food & Drug Administration has approved Johnson & Johnson's device for a type of condition which causes abnormal ...

Woodland Heights Medical Center is pleased to announce treatment of its first patient with a new system that used Pulsed ...

Boston Scientific ( NYSE: BSX) has agreed to acquire privately held medical technology company, Cortex, Inc.

Expanding its portfolio further into cardiovascular health, Marlborough medical device manufacturer Boston Scientific has ...

Growth of the market is driven by the prevalence of atrial fibrillation cases and cardiac disorders, a rise in the number of hypertension patients, growth in the geriatric population, and increasing ...

AtriCure stock rose more than 16% on news of plans to expand into pulsed field ablation, a tech that could potentially better treat AFib.